Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
ICCFASD SBI Working Group for Pregnant and Postpartum People (ISBI-WG) (ISBI) Committee, Work group, Advisory group, or Task Force AHRQ, ASPE, CDC, CMS, IHS, HRSA, SAMHSA NIAAA, NIDA This is a special interest working group formed and led by the ICCFASD. The objectives of the ISBI working group are to exchange information and resources, identify gaps and opportunities for improved implementation and research, and expand collaboration and partnerships between federal agencies. The group includes representatives from the ICCFASD and other federal agencies.
ICCVAM Ecotoxicology Workgroup (EcoWG) Committee, Work group, Advisory group, or Task Force FDA NIEHS ICCVAM workgroup that provides expertise in identifying and evaluating in vitro and in silico methods to identify ecological and environmental hazards.
ICCVAM In Vitro to In Vivo Extrapolation Workgroup (IVIVE-WG) Committee, Work group, Advisory group, or Task Force ATSDR, FDA NIEHS, NLM ICCVAM workgroup established to catalog and evaluate currently available IVIVE approaches, to determine their suitability for specific research or regulatory purposes, and to assess whether additional tools or models are needed.
ICCVAM Metrics Workgroup (MWG) Committee, Work group, Advisory group, or Task Force FDA NIEHS, OD ICCVAM workgroup established to develop objectives and determine how agencies can best address the recommendations in the 2019 GAO report, "Animal Use in Research"
ICCVAM Nanomaterials Workgroup (NanoWG) Committee, Work group, Advisory group, or Task Force FDA, CDC NIEHS ICCVAM workgroup established to evaluate the suitability of alternative methods to assess potential toxicity of nanomaterials.
ICCVAM Public Forum Meeting/ Workshop FDA NIEHS, NCATS ICCVAM holds annual public forums to promote national and international partnerships between governmental and nongovernmental groups, including academia, industry, advocacy groups, and other key stakeholders. The 2020 Public Forum was held on May 21.
ICCVAM Read Across Workgroup (RAWG) Committee, Work group, Advisory group, or Task Force ATSDR, FDA NIEHS, NLM ICCVAM workgroup established to build read-across capacity within member agencies, raise awareness of the state of the science, and work towards harmonization of read-across approaches.
Identification and Validation of ctDNA Quality Control Materials Resource Development FDA NCI The ctDNA Quality Control Materials project seeks to develop a set of nationally recognized standards to enable the production of suitable quality control materials for widespread use in testing for circulating tumor DNA (ctDNA).
Image-guided Interventional Therapeutics Research Initiative FDA CC, NCI This collaboration will lead to safer and more effective treatment planning and performance of image-guided interventions and therapeutic drug delivery. The results of all of these studies of image-guided interventions and related technologies and the models used to study them will have a direct impact on the effectiveness and consistency of the Food and Drug Administration (FDA) Center for Devices and Radiological Health's preclinical review of device applications while meeting the primary research goal of optimizing image-guided interventions and pre-clinical modeling of those interventions. Regulatory science and translational therapeutics have overlapping goals when it comes to drugs and devices combination therapies.
Immunology Interest Group Meeting/ Workshop FDA NCI, NIDDK, NHLBI, NIAID, NINDS, NIEHS, CC, NIAMS, NEI, NIDCR, NICHD, NIAAA, NIMH, NHGRI, NCCIH, NIA, NIDA, NIDCD, NIGMS, NIMHD, OD/OIR The National Institute of Health (NIH) Immunology Interest Group (IIG) brings together immunologists from across all NIH institutes as well as the Food and Drug Administration (FDA). The two major activities of the IIG are a Wednesday afternoon lecture series highlighting world-class immunologists and intramural immunologists and an annual workshop where up to 350 NIH/FDA immunologists get together to present their work to the community.